A. Sundstedt

发表

Tasquinimod triggers an early change in the polarization of tumor associated macrophages in the tumor microenvironment

T. Leanderson, Anders Olsson, J. Nakhlé, 2015, Journal of Immunotherapy for Cancer.

Immune response during tumor therapy with antibody‐superantigen fusion proteins

J. Hansson, T. Kalland, A. Sundstedt, 1996, International journal of cancer.

G. Hedlund, M. Nilsson, A. Sundstedt, 2013 .

Immunotherapy with tumor-targeted superantigens (TTS) in combination with docetaxel results in synergistic anti-tumor effects.

G. Hedlund, A. Sundstedt, G. Forsberg, 2009, International immunopharmacology.

IL-2 Unresponsiveness in Anergic CD4+ T Cells Is Due to Defective Signaling Through the Common γ-Chain of the IL-2 Receptor1

A. Sundstedt, M. Dohlsten, Susanna Grundström, 2000, The Journal of Immunology.

Superantigen‐induced cytokines suppress growth of human colon‐carcinoma cells

M. Björklund, T. Kalland, G. Hedlund, 1993, International journal of cancer.

Intranasal peptide-induced peripheral tolerance: the role of IL-10 in regulatory T cell function within the context of experimental autoimmune encephalomyelitis.

D. Wraith, S. Anderton, A. Sundstedt, 2002, Veterinary immunology and immunopathology.

Selective induction of p38 mitogen-activated protein kinase activity following A6H co-stimulation in primary human CD4(+) T cells.

A. Sundstedt, M. Dohlsten, T. Labuda, 2000, International immunology.

Regulatory T Cells In Vivo + CD 25 + the Presence or Absence of Natural CD 4 Display Different Suppressive Functions in Superantigen-Induced Regulatory T Cells

A. Sundstedt, F. Ivars, P. Scheipers, 2003 .

Superantigen-Induced Regulatory T Cells Display Different Suppressive Functions in the Presence or Absence of Natural CD4+CD25+ Regulatory T Cells In Vivo1

A. Sundstedt, F. Ivars, P. Scheipers, 2003, The Journal of Immunology.

Natural and Induced Regulatory T Cells

D. Wraith, A. Sundstedt, G. Mazza, 2004, Annals of the New York Academy of Sciences.

Role for IL-10 in Suppression Mediated by Peptide-Induced Regulatory T Cells In Vivo 1

D. Wraith, A. Sundstedt, E. O’Neill, 2003, The Journal of Immunology.

Peptide-Induced Regulatory T Cells In Vivo Role for IL-10 in Suppression Mediated by

A. Sundstedt, E. O’Neill, E. O'Neill, 2003 .

Selective induction of p 38 mitogen-activated protein kinase activity following A 6 H co-stimulation in primary human CD 4 T cells

A. Sundstedt, M. Dohlsten, T. Labuda, 2000 .

In vivo anergized CD4+ T cells have defective expression and function of the activating protein-1 transcription factor.

A. Sundstedt, M. Dohlsten, 1998, Journal of immunology.

Activating Protein-1 Transcription Factor Defective Expression and Function of the T Cells Have + In Vivo Anergized CD 4

A. Sundstedt, M. Dohlsten, 1998 .

for Their Growth, Differentiation, and Are Independent of CD25+ Regulatory Cells Antigen-Induced IL-10+ Regulatory T Cells

D. Wraith, A. Sundstedt, E. O’Neill, 2013 .

Antigen-Induced IL-10+ Regulatory T Cells Are Independent of CD25+ Regulatory Cells for Their Growth, Differentiation, and Function1

D. Wraith, S. Minaee, A. Sundstedt, 2006, The Journal of Immunology.

CD 25 Regulatory T Cells + Antigen-Induced IL-10

D. Wraith, S. Minaee, A. Sundstedt, 2006 .

Differential activation of signal transducer and activator of transcription (STAT)3 and STAT5 and induction of suppressors of cytokine signalling in T(h)1 and T(h)2 cells.

D. Wraith, P. Anderson, A. Sundstedt, 2003, International immunology.

Bcl-3 and NFκB p50-p50 Homodimers Act as Transcriptional Repressors in Tolerant CD4+ T Cells*

P. Anderson, A. Sundstedt, P. Scheipers, 2004, Journal of Biological Chemistry.

Immunological response and overall survival in a subset of advanced renal cell carcinoma patients from a randomized phase 2/3 study of naptumomab estafenatox plus IFN-α versus IFN-α

G. Hedlund, D. Burt, R. Hawkins, 2015, Oncotarget.

Amelioration of experimental autoimmune encephalomyelitis by the quinoline-3-carboxamide paquinimod: reduced priming of proinflammatory effector CD4(+) T cells.

T. Leanderson, A. Sundstedt, Adnan Deronic, 2013, The American journal of pathology.

Immunoregulatory role of IL-10 during superantigen-induced hyporesponsiveness in vivo.

N. Van Rooijen, T. Kalland, A. Sundstedt, 1997, Journal of immunology.

In vivo anergized CD4+ T cells express perturbed AP-1 and NF-kappa B transcription factors.

M. Sigvardsson, T. Leanderson, T. Kalland, 1996, Proceedings of the National Academy of Sciences of the United States of America.

Targeting of superantigens

L. Abrahmsén, T. Kalland, G. Hedlund, 2009, Cell Biophysics.

Monoclonal antibodies and superantigens: A novel therapeutic approach

T. Kalland, G. Hedlund, A. Sundstedt, 1993, Medical oncology and tumor pharmacotherapy.

Bispecific antibodies targeting CD40 and tumor-associated antigens promote cross-priming of T cells resulting in an antitumor response superior to monospecific antibodies

Deniz A. Bölükbas, A. Sundstedt, Adnan Deronic, 2022, Journal for immunotherapy of cancer.

Combining tumor-targeted superantigens with interferon-alpha results in synergistic anti-tumor effects.

G. Hedlund, A. Sundstedt, Mona Celander, 2008, International immunopharmacology.

Superantigen-induced anergy in cytotoxic CD8+ T cells.

J. Hansson, T. Kalland, G. Hedlund, 1995, Journal of immunology.

Immunopharmacology of the superantigen staphylococcal enterotoxin A in T-cell receptor V beta 3 transgenic mice.

M. Björklund, T. Kalland, G. Hedlund, 1993, Immunology.

Pharmacological modulation of T cell immunity results in long-term remission of autoimmune arthritis

L. Salford, S. Luo, Richard O. Williams, 2021, Proceedings of the National Academy of Sciences.

Role for IL-10 in Suppression Mediated by Peptide-Induced Regulatory T Cells In Vivo

A. Sundstedt, E. O’Neill, 2003 .

Cytokine-Induced Src Homology 2 Protein (Cis) Promotes T Cell Receptor–Mediated Proliferation and Prolongs Survival of Activated T Cells

S. Karlsson, P. Anderson, Shangwu Chen, 2000, The Journal of experimental medicine.

Superantigens anergize cytokine production but not cytotoxicity in vivo.

M. Björklund, T. Kalland, G. Hedlund, 1994, Immunology.

IL-2 Overcomes the Unresponsiveness but Fails to Reverse the Regulatory Function of Antigen-Induced T Regulatory Cells1

D. Wraith, P. Anderson, S. Minaee, 2005, The Journal of Immunology.

Antigen-Induced T Regulatory Cells Fails to Reverse the Regulatory Function of IL-2 Overcomes the Unresponsiveness but

D. Wraith, S. Minaee, A. Sundstedt, 2004 .

Tasquinimod Modulates Suppressive Myeloid Cells and Enhances Cancer Immunotherapies in Murine Models

L. Ellis, T. Leanderson, S. Ramakrishnan, 2014, Cancer Immunology Research.

IL-2 Overcomes the Unresponsiveness but Fails to Reverse the Regulatory Function of Antigen-Induced T Regulatory Cells

D. Wraith, P. Anderson, S. Minaee, 2005, The Journal of Immunology.

The Tumor Targeted Superantigen ABR-217620 Selectively Engages TRBV7-9 and Exploits TCR-pMHC Affinity Mimicry in Mediating T Cell Cytotoxicity

B. Jakobsen, G. Hedlund, K. Lindkvist-Petersson, 2013, PloS one.

Persistent antigenic stimulation alters the transcription program in T cells, resulting in antigen‐specific tolerance

Sabah Khalid, Alistair Symonds, Suling Li, 2006, European journal of immunology.

The role of cytokines in immunological tolerance: potential for therapy

A. Sundstedt, D. Wraith, M. Harber, 2000, Expert Reviews in Molecular Medicine.

Monotherapeutically Nonactive CTLA-4 Blockade Results in Greatly Enhanced Antitumor Effects When Combined With Tumor-targeted Superantigens in a B16 Melanoma Model

G. Hedlund, A. Sundstedt, M. Törngren, 2012, Journal of immunotherapy.

The Wiskott-Aldrich Syndrome Protein Regulates Nuclear Translocation of NFAT2 and NF-κB (RelA) Independently of Its Role in Filamentous Actin Polymerization and Actin Cytoskeletal Rearrangement1

Sambasiva P Rao, T. Manser, K. Vora, 1988, The Journal of Immunology.